Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials
Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials. Their initial product is a sealant patch designed for rapid hemostasis in abdominopelvic procedures, leveraging biomaterials successfully used in various medical applications for over 10 million patients.